ID2
DNA-binding protein inhibitor ID-2
You are using an outdated browser. Please upgrade your browser to improve your experience.
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
biological process | 1 | ||
gene perturbation | 1 | ||
PubMedID | 1 | ||
transcription factor perturbation | 1 | ||
kinase perturbation | 0.96 | ||
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
- OR - satisfy the following criterion:
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Target has at least one approved drug - AND - satisfies the preceding conditions
PDB Structure Id | Ligand | Method | Resolution (Ã…) | M.W. (kDa) | Pub Year | Title |
---|
PDB Structure Id | M.W. | Resolution | Pub Year |
---|
Data Source | Name | Explore in Pharos | Explore in Source | ||
---|---|---|---|---|---|
KEGG | TGF-beta signaling pathway | ||||
KEGG | Signaling pathways regulating pluripotency of stem cells | ||||
KEGG | Hippo signaling pathway | ||||
KEGG | Transcriptional misregulation in cancer | ||||
Name | Explore in Pharos | Explore in Source | ||
---|---|---|---|---|
TGF-beta signaling pathway | ||||
Signaling pathways regulating pluripotency of stem cells | ||||
Hippo signaling pathway | ||||
Transcriptional misregulation in cancer | ||||
GO Term | Evidence | Assigned by | ||
---|---|---|---|---|
Inferred from Physical Interaction (IPI) | BHF-UCL | |||
Inferred from Biological aspect of Ancestor (IBA) | GO_Central | |||
Inferred from Biological aspect of Ancestor (IBA) | GO_Central | |||
Inferred from Biological aspect of Ancestor (IBA) | GO_Central | |||
Inferred from Sequence Model (ISM) | NTNU_SB | |||
Inferred from Electronic Annotation (IEA) | InterPro | |||